Abstract: The invention relates to a device and a method for generating a positive pressure in a tank for liquefied gas on a refrigerated vehicle with an evaporator for the liquefied gas, in conjunction with which the evaporator is connected in a fluid-conducting fashion to the tank via a line for liquefied gas, and in conjunction with which a valve is arranged in the line, comprising the following method steps: opening the valve so that liquefied gas exits from the tank and into the line; closing the valve in such a way that a quantity of the liquefied gas remains in the line and is able to flow back into the tank; heating the quantity in the line. The invention also relates to a method for the supply of liquefied gas, and a device for generating a positive pressure in a tank for liquefied gas in a cooling system, in conjunction with which the method according to the invention for generating a pressure is utilized.

Abstract: The present invention relates to a supply station jointly storing a low-temperature-liquefied combustible gas, in particular natural gas, and liquid nitrogen and designed for supplying each component separately or jointly as needed to a vehicle, the supply station being present on the vehicle, the station comprising at least a first storage tank for storing said liquefied combustible gas; and at least a second storage tank for storing said liquid nitrogen and at least one heat-transmitting connection element between the at least one first storage tank and the at least one second storage tank, which connection element is designed so that the combustible gas can be cooled, or can be maintained at a temperature below its boiling point, directly or indirectly by the liquid nitrogen.

Abstract: The present invention relates to a method and a device for refilling a stationary storage tank with a subcooled cryogenically liquefied gas from a tanker. A subcooler, comprising a cooling bath and connected between the tanker and an inlet of the storage tank, is filled with the liquefied gas from the tanker up to a filling level and cooled to a bath temperature. The storage tank is subsequently refilled with the liquefied gas from the tanker by the liquefied gas being pumped through a heat exchanger in the cooling bath of the subcooler into the storage tank by using a delivery pump, during which it is cooled to the bath temperature of the cooling bath. After the end of the filling process, the subcooler is no longer supplied with liquefied gas and therefore heats up.

Abstract: The present invention relates to a supply station jointly storing a low-temperature-liquefied combustible gas, in particular natural gas, and liquid nitrogen and designed for supplying each component separately or jointly as needed to a vehicle, the supply station being present on the vehicle, the station comprising at least a first storage tank for storing said liquefied combustible gas; and at least a second storage tank for storing said liquid nitrogen and at least one heat-transmitting connection element between the at least one first storage tank and the at least one second storage tank, which connection element is designed so that the combustible gas can be cooled, or can be maintained at a temperature below its boiling point, directly or indirectly by the liquid nitrogen.

Abstract: The present invention relates to a refrigeration vehicle comprising at least one refrigeration space, which can be cooled via at least one supplemental heat exchanger. The supplemental heat exchanger in the refrigeration space is connected to other components, preferably via couplings and flexible lines, establishing a heat exchange loop being able to exchange heat with an evaporator for low-temperature liquefied combustible gas. Moreover the Refrigeration vehicle comprises at least one first vehicle part and one second vehicle part being dividable and wherein the first vehicle part comprises an internal combustion engine and the evaporator for the low-temperature liquefied combustible gas.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline propyl sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: A method for managing access to a confined space which is cooled by the direct injection of a cryogenic fluid, comprising at least one system for closing the confined space, which can prevent access to said confined space and can be opened/closed to a variable and controllable degree, and a data acquisition and processing device. The device can: control the open or closed state of the closure system; set and control the degree to which the closure system is open/closed; ensure that a time delay (TP) is respected every time the closure system is closed, after which time delay the injection of cryogenic fluid into the space resumes; and, at the request of a user, implement the cycle for opening the closure system. The device determines the time that has elapsed (TE) in the closed position since the last closure cycle of the closure system and compares TE to TP. If TE=TP the device immediately authorizes the opening of the closure system.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to a method for monitoring the gas tightness of a cooling system for a refrigerated vehicle comprising the following steps: recording of a chronological temperature sequence at least at a first point in the cooling system and the determination of any change in the temperature at the first point within a first time interval and comparison of the change with a first reference value and the triggering of a first warning signal in the event that the change exceeds the first reference value; and/or subjecting a line section of the cooling system to a positive pressure and blocking this line section and recording a chronological pressure sequence at least at a first point in the line section and the determination of any change in the pressure in the second point within a second time interval and comparison of the change with a second reference value and the triggering of a second warning signal in the event that the change exceeds the second reference value.

Abstract: The invention relates to a mobile refrigerated vehicle comprising a refrigerated chamber housing for at least one refrigerated chamber contained therein, a tank for liquefied gas, an evaporator for the evaporation of the liquefied gas during the delivery of cold to the refrigerated chamber and an exhaust pipe for the evaporated gas, in conjunction with which the evaporator is arranged outside the refrigerated chamber; and a method for refrigerating a refrigerated chamber of a mobile refrigerated vehicle comprising the following process stages: removal of a liquefied gas from a tank and supply of the gas into an evaporator arranged outside the refrigerated chamber; removal of a flow of cooling air to be refrigerated from the refrigerated chamber, evaporation of the liquefied gas in the evaporator and utilization of at least one part of the cold content for the refrigeration of the flow of cooling air; introduction of the refrigerated flow of cooling air into the refrigerated chamber.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to a heat exchanger for a mobile refrigerated vehicle having a tank for liquefied gas comprising a pipe for accepting a flow of a liquefied gas and for the evaporation of at least one part of the liquefied gas, in conjunction with which the pipe, at least in sections, exhibits a longitudinal axis, and the heat exchanger comprises an inlet side for liquefied gas and an outlet side for at least partially evaporated gas, and in conjunction with which the outlet side is connected to an exhaust pipe in such a way as to permit a flow, in conjunction with which the pipe exhibits elements in its interior for the purpose of generating turbulences in the flow or a radial phase separation. The invention is characterized in that, with the help of the elements, the thickness of a gas interface layer on a wall of the pipe, which occurs as a result of vaporization of the gas, is reduced considerably, whereby the efficiency of the heat exchanger is increased considerably.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to a device and a method for generating a positive pressure in a tank for liquefied gas on a refrigerated vehicle with an evaporator for the liquefied gas, in conjunction with which the evaporator is connected in a fluid-conducting fashion to the tank via a line for liquefied gas, and in conjunction with which a valve is arranged in the line, comprising the following method steps: opening the valve so that liquefied gas exits from the tank and into the line; closing the valve in such a way that a quantity of the liquefied gas remains in the line and is able to flow back into the tank; heating the quantity in the line. The invention also relates to a method for the supply of liquefied gas, and a device for generating a positive pressure in a tank for liquefied gas in a cooling system, in conjunction with which the method according to the invention for generating a pressure is utilized.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some 2,2a,4,5-tetrahydro-1H-3-aza-acenaphthylen substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.

Abstract: A pair of brake levers each having a brake shoe thereon acting in opposite directions against a brake drum have one end pivotally mounted and the other end of one brake lever is pivotally connected to a pivotally mounted operating lever. A rod is pivotally connected between the other brake lever and the operating lever. The operating lever is moved in the non-braking direction by an actuator and a spring pivots the operating lever in the other direction to apply the brake shoes. The end of the rod pivotally connected to the operating lever has a uni-directional drive thereon to adjust the effective length of the rod only when the operating lever is moved in the non-braking direction to compensate for wear of the brake shoes.